Cargando…

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi

Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter Erlank, Chelsey, Ali, Gracious, Birhanu, Frehiwot, Stanley, Melinda, Chirwa, Jessie Salamba, Kachale, Fannie, Gunda, Andrews
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688740/
https://www.ncbi.nlm.nih.gov/pubmed/38032864
http://dx.doi.org/10.1371/journal.pgph.0002057
_version_ 1785152227990568960
author Porter Erlank, Chelsey
Ali, Gracious
Birhanu, Frehiwot
Stanley, Melinda
Chirwa, Jessie Salamba
Kachale, Fannie
Gunda, Andrews
author_facet Porter Erlank, Chelsey
Ali, Gracious
Birhanu, Frehiwot
Stanley, Melinda
Chirwa, Jessie Salamba
Kachale, Fannie
Gunda, Andrews
author_sort Porter Erlank, Chelsey
collection PubMed
description Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than early acceptability studies suggested. Providers play an instrumental role in building client confidence to self-inject through counselling/training. This cross-sectional qualitative study explored the perspectives of providers and injectable clients on the integration of self-injection into contraceptive counselling, to identify best practices and potential gaps. The study was conducted at public sector sites in three districts (Nkhotakota, Mzimba South, Zomba) in Malawi. In-depth interviews were conducted with provider-administered injectable clients, self-injecting clients, and DMPA-SC trained providers. All providers interviewed reported successfully integrating self-injection into their approach. During group health education sessions, some providers reported focusing on benefits of self-injection to spark interest in the method, and then follow that up with more in-depth information during individual counselling. Due to time pressures, a minority of providers reported replacing individual counselling with small-group counselling and limited use of elements such as visualizations and demonstrations. Most providers skipped client practice on inanimate objects, feeling this was either not necessary or inappropriate given stock constraints. Self-injection clients tended to credit their decision to take up SI to receiving lengthy, comprehensive counselling/training, often inclusive of reassuring messages, visualizations, demonstrations and sometimes repeated trainings over time. Provider-administered clients tended to credit their lack of uptake of self-injection to fear and lack of confidence, often blaming themselves instead of the quality of their counselling/training–even while many felt their counselling/training had been rushed or incomplete. Providers should be supported to overcome time- and resource-pressures to invest in counselling/training best practices, to ensure sufficient support is provided to clients interested in self-injection.
format Online
Article
Text
id pubmed-10688740
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-106887402023-12-01 Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi Porter Erlank, Chelsey Ali, Gracious Birhanu, Frehiwot Stanley, Melinda Chirwa, Jessie Salamba Kachale, Fannie Gunda, Andrews PLOS Glob Public Health Research Article Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than early acceptability studies suggested. Providers play an instrumental role in building client confidence to self-inject through counselling/training. This cross-sectional qualitative study explored the perspectives of providers and injectable clients on the integration of self-injection into contraceptive counselling, to identify best practices and potential gaps. The study was conducted at public sector sites in three districts (Nkhotakota, Mzimba South, Zomba) in Malawi. In-depth interviews were conducted with provider-administered injectable clients, self-injecting clients, and DMPA-SC trained providers. All providers interviewed reported successfully integrating self-injection into their approach. During group health education sessions, some providers reported focusing on benefits of self-injection to spark interest in the method, and then follow that up with more in-depth information during individual counselling. Due to time pressures, a minority of providers reported replacing individual counselling with small-group counselling and limited use of elements such as visualizations and demonstrations. Most providers skipped client practice on inanimate objects, feeling this was either not necessary or inappropriate given stock constraints. Self-injection clients tended to credit their decision to take up SI to receiving lengthy, comprehensive counselling/training, often inclusive of reassuring messages, visualizations, demonstrations and sometimes repeated trainings over time. Provider-administered clients tended to credit their lack of uptake of self-injection to fear and lack of confidence, often blaming themselves instead of the quality of their counselling/training–even while many felt their counselling/training had been rushed or incomplete. Providers should be supported to overcome time- and resource-pressures to invest in counselling/training best practices, to ensure sufficient support is provided to clients interested in self-injection. Public Library of Science 2023-11-30 /pmc/articles/PMC10688740/ /pubmed/38032864 http://dx.doi.org/10.1371/journal.pgph.0002057 Text en © 2023 Porter Erlank et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Porter Erlank, Chelsey
Ali, Gracious
Birhanu, Frehiwot
Stanley, Melinda
Chirwa, Jessie Salamba
Kachale, Fannie
Gunda, Andrews
Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
title Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
title_full Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
title_fullStr Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
title_full_unstemmed Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
title_short Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
title_sort health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (dmpa-sc) for self-injection in malawi
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688740/
https://www.ncbi.nlm.nih.gov/pubmed/38032864
http://dx.doi.org/10.1371/journal.pgph.0002057
work_keys_str_mv AT portererlankchelsey healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi
AT aligracious healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi
AT birhanufrehiwot healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi
AT stanleymelinda healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi
AT chirwajessiesalamba healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi
AT kachalefannie healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi
AT gundaandrews healthcareproviderandclientexperiencesofcounsellingondepotmedroxyprogesteroneacetatesubcutaneousdmpascforselfinjectioninmalawi